Publications

Publication list with DDOP association

*Bold dark blue text for DDOP Director

*Blue text for DDOP current/past team members

1. H. Tee, U. Vijayakumar, M. Shanmugasundaram, T.Y.W. Lam, W. Liao, Y. Yang, W.S.F. Wong, R. Ge (2023) Isthmin-1 attenuates allergic asthma by stimulating adiponectin expression and alveolar macrophage efferocytosis in mice. Respir. Res. In Press.

2. X.L. Gan, W. Liao, H.F. Lim, W.S.F. Wong (2023) Dexamethasone protects against Aspergillus fumigatus-induced severe asthma via modulating pulmonary immunometabolism. Pharmacol. Res. 196:106929 [IF=10.334]

3. T.N. Tran, P.X.L. Gan, W. Liao, Y.K. Mok, Christina L.L. Chai, W.S.F. Wong (2023) Degradation of MK2 with natural compound andrographolide: a new modality for anti-inflammatory therapy. Pharmacol. Res. 194:106861 [IF=10.334]

4. D.T. Tram, Q.T.N. Tran, J. Xu, J.C.T. Su, W. Liao, W.S.F. Wong, P.L.R. Ee (2023) Multifunctional antibacterial nanonets attenuate inflammatory responses through selective trapping of endotoxins and pro-inflammatory cytokines. Adv Healthc Mater. 2203232 [IF=11.092]

5. Liao, W.S.F. Wong (2023) Anti-oxidative and anti-inflammatory properties of xanthorrhizol in airway inflammation. J. Basic Appl. Pharmacol. 2:74-87 [Invited]

6. Mei, W. Liao, P.X.L. Gan, Q.T.N. Tran, C.C.M.Y. Chan, C.K.M. Heng, W.S.F. Wong (2022) Angiotensin II type-2 receptor activation in alveolar macrophages mediates protection against cigarette smoke-induced chronic obstructive pulmonary disease. Pharmacol. Res. 184:106469 [IF=10.334]

7. Liao, H.Y.C. Foo, T.N.Q. Tran, C.L.L. Chai, W.S.F. Wong (2022) Calcaratarin D, a labdane diterpenoid, attenuates mouse asthma via modulating alveolar macrophage function. Br. J. Pharmacol. 180:1056-1071. [IF=9.473]
   

8. Nguyen, S. Xu, T.Y.W. Lam, W. Liao, W.S.F. Wong, R. Ge (2022) ISM1 suppresses LPS-induced acute lung injury and post-injury lung fibrosis in mice. Mol. Med. 28:72 [IF=6.376]
   

9. K.M. Chew, I. Darlyuk-Saadon, N. Gilad, W.S.F. Wong, D. Engelberg (2022) Targeting p38a MAPK in chronic inflammation: could activation, not inhibition, be the appropriate therapeutic strategy. Pharmacol. Ther. 235:108153. [IF=13.40]
   

10. T.N. Tran, W.S.D. Tan, W.S.F. Wong, C.L.L. Chai (2021) From irreversible to reversible covalent inhibitors: harnessing the andrographolide scaffold for anti-inflammatory action. Eur. J. Med. Chem. 204: 112481. [IF=7.088]

11. N.Q. Tran, W.S.D. Tan, W.S.F. Wong, C.L.L. Chai (2020) Polypharmacology of andrographolide: beyond one molecule one target. Nat. Prod. Rep. 38:682-692. [IF=15.111]